Applying New Pneumococcal Vaccine Recommendations to Practice: An Interactive Case-Based Learning Program for Pharmacists

Master the current approaches to pneumococcal vaccine through case-based learning.




In response to the recent introduction of 15-valent and 20-valent pneumococcal conjugate vaccines in Canada, the National Advisory Committee on Immunization (NACI) published a statement on their recommended use within public health programs. Following a review of pneumococcal disease and the available vaccine options, this program will use an interactive case-based approach to prepare pharmacists to identify patients eligible for vaccination and recommend the most appropriate vaccine for protection against pneumonia and invasive pneumococcal disease. 

This session is brought to you by an educational grant from: 

Learning objectives:

By the end of this course, you should be able to:  

  • Differentiate available pneumococcal vaccine products based on preparation (conjugate or polysaccharide), serotype coverage, and indications 
  • Identify everyday opportunities in community practice to screen for patients eligible for pneumococcal vaccination 
  • Apply NACI recommendations to patient cases that may be encountered in practice 

Course outline:

  • Learning modules (1.5 hours)
    Module 1: Applying New Pneumococcal Vaccine Recommendations to Practice
    Module 2: The Interactive Cases
  • Multiple-Choice Exam
  • Program Evaluation

Course at a glance:

Who should take this course:

All injection-certified pharmacy professionals who would like to know more about pneumococcal vaccines and patient eligibility.  

Development Team: